Skip to content

Characteristic mechanisms of post-stroke cognitive impairment

Characteristic mechanisms of post-stroke cognitive impairment

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400089609
Enrollment
Unknown
Registered
2024-09-11
Start date
2024-09-11
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-stroke cognitive impairment

Interventions

Post-stroke cognitive impairment (PSCI) group:none, observational study
Non-PSCI group:none, observational study
Healthy control group:none, observational study

Sponsors

china rehabilitation research center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients with stroke Enrollment criteria (1) Patients who met the diagnostic criteria of ischemic stroke or hemorrhagic stroke [5-8] and had ischemic or hemorrhagic stroke confirmed by computed tomography (CT) or magnetic resonance imaging (MRI); (2) First stroke, or onset without significant sequelae; (3) Disease duration of 3-12 months; (4) Age 35-75 years; (5) Stroke site located on the unilateral curtain; Note: PSCI is mild-to-moderate cognitive impairment: MMSE =10 points and MoCA <26 points or MMSE <27 points; NPSCI is MMSE =27 points or MoCA =26 points. (6) Signed informed consent. 2 Healthy control Inclusion criteria: (1) Age 35-75 years old; (2) In good health, without any acute or chronic diseases. (3) No history of major surgery or severe trauma.

Exclusion criteria

Exclusion criteria: 1. Patients with stroke Exclusion criteria (1) Mild cognitive impairment diagnosed before stroke, cognitive dysfunction due to diseases other than stroke such as Alzheimer's disease, frontotemporal lobe dementia, dementia with Lewy bodies, vascular dementia, Parkinson's disease dementia, acquired traumatic brain injury, and so on; (2) Presence of a history of drug or alcohol abuse, history of other psychiatric disorders; (3) Patients with comorbid primary diseases that cannot be controlled with conventional medications; and (4) Combination of malignant hypertension and malignant tumor; and (5) Patients with severe infections, water, electrolyte and acid-base balance disorders; (6) Patients who, in the judgment of the investigator, are not eligible for the study. (6) Other abnormal conditions that do not meet the conditions of the trial in the judgment of the investigator. 2 Healthy control Exclusion criteria: (1) Presence of current history of any acute or chronic disease. (2) Presence of a history of drug or alcohol abuse, a history of other mental illness, or current comorbid severe depression or anxiety; (3) Other unusual conditions that, in the judgment of the investigator, do not qualify for the trial.

Design outcomes

Primary

MeasureTime frame
functional magnetic resonance imaging (fMRI);Montreal cognitive assessment scale;

Countries

China

Contacts

Public ContactZhang Hao

China rehabilitation research center

1262752286@QQ.COM+86 137 0135 6685

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026